Indivior Pharmaceuticals Inc.
Organization details
- Legal name
- Indivior Pharmaceuticals Inc.
- Former names
- Indivior PLC
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- North Chesterfield
- Headquarters state / province
- Virginia
- Headquarters country
- United Kingdom
- Fiscal year end
- December
- Ticker symbol
- INDV
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001625297
- EIN
- 41-2520873
Board of directors
-
Barbara Ryan · DirectorSince 2026
-
Bethany Sensenig · DirectorSince 2026
-
Carrolee Barlow · DirectorSince 2026
-
Daniel A. Ninivaggi · DirectorSince 2026
-
David E. Wheadon · DirectorSince 2026
-
Georges Gemayel · DirectorSince 2026
-
Jack A. Khattar · Director · Chief Executive OfficerSince 2026
-
Joseph Ciaffoni · Director · Chief Executive OfficerSince 2026
-
Juliet Thompson · DirectorSince 2026
-
Keith Humphreys · DirectorSince 2026
-
Mark Stejbach · DirectorSince 2026
-
Stuart A. Kingsley · DirectorSince 2026
Chief executives
Director election results
Annual meeting of May 13, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.2%
-
98.4%
-
98.6%
-
99.2%
-
99.9%
-
99.9%
-
99.9%
Board connections
8 of this board's directors also sit on 11 other boards. 10 are in the same sector.
-
Supernus Pharmaceuticals Inc. Same sectorvia Bethany Sensenig, Carrolee Barlow, Georges Gemayel and Jack A. Khattar
-
Alpha Cognition Inc. Same sectorvia Bethany Sensenig
-
Azitra Inc Same sectorvia Barbara Ryan
-
Cognition Therapeutics Inc. Same sectorvia Jack A. Khattar
-
Collegium Pharmaceutical Inc. Same sectorvia Joseph Ciaffoni
-
Disc Medicine Inc. Same sectorvia Georges Gemayel
- via Daniel A. Ninivaggi
-
INVO Fertility Inc. Same sectorvia Barbara Ryan
-
MiNK Therapeutics Inc. Same sectorvia Barbara Ryan
-
Seaport Therapeutics Inc. Same sectorvia David E. Wheadon
-
Sotera Health Company Same sectorvia David E. Wheadon
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $311,556
- 10 purchases by 7 insiders
- Sold, last 12 months
- $2,829,211
- 3 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Carrolee Barlow Director | Other | +41,652 | — | — |
| Nov 2, 2026 | Bhatt Padmanabh P. Officer (SVP of IP, CSO) | Other | +28,702 | — | — |
| Nov 2, 2026 | DEC TIMOTHY C Officer (SVP, Chief Financial Officer) | Other | +14,059 | — | — |
| Nov 2, 2026 | Georges Gemayel Director | Other | +42,009 | — | — |
| Nov 2, 2026 | Jack A. Khattar Director, Officer (Chief Executive Officer) | Other | +1,937,986 | — | — |
| Nov 2, 2026 | Mottola Frank Officer (SVP, Chief Tech. Ops. Officer) | Other | +30,099 | — | — |
| Nov 2, 2026 | Rubin Jonathan Officer (SVP, Chief Medical Officer) | Other | +21,529 | — | — |
| Nov 2, 2026 | Jack A. Khattar Director, Officer (Chief Executive Officer) | Other | +1,475,569 | — | — |
| Aug 27, 2026 | Anderson Woodrow D Officer (Chief Accounting Officer) | Open-market purchase | +1,500 | $35.69 | $53,535 |
| Aug 5, 2026 | Anderson Woodrow D Officer (Chief Accounting Officer) | Open-market purchase | +1,500 | $36.28 | $54,420 |
| Jul 10, 2026 | Heidbreder Christian Officer (Chief Scientific Officer) | Open-market sale | −18,586 | $41.14 | $764,628 |
| Jun 22, 2026 | Joseph Ciaffoni Director, Officer (Chief Executive Officer) | Option exercise | +1,266,903 | — | — |
| Jun 22, 2026 | Joseph Ciaffoni Director, Officer (Chief Executive Officer) | Shares withheld for tax | −612,549 | $38.32 | $23,472,878 |
| Jun 11, 2026 | Heidbreder Christian Officer (Chief Scientific Officer) | Open-market sale | −18,586 | $38.06 | $707,383 |
| Jun 8, 2026 | Preblick Ryan Officer (Chief Financial Officer) | Open-market sale | −36,000 | $37.70 | $1,357,200 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Indivior Pharmaceuticals Inc.
Who is the CEO of Indivior Pharmaceuticals Inc.?
Jack A. Khattar has been Indivior Pharmaceuticals Inc.'s Chief Executive Officer since November 2026.
How many directors are on Indivior Pharmaceuticals Inc.'s board?
Indivior Pharmaceuticals Inc.'s board has 12 directors: Barbara Ryan, Bethany Sensenig, Carrolee Barlow, Daniel A. Ninivaggi, David E. Wheadon, Georges Gemayel, Jack A. Khattar, Joseph Ciaffoni, Juliet Thompson, Keith Humphreys and 2 others.
Are Indivior Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Indivior Pharmaceuticals Inc. insiders bought $311,556 of shares in 10 purchases and sold $2.8 million of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="indivior-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.